Genomic Health (GHDX) Reports Q3 Loss Per Share of 36c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Genomic Health Reports Highest Test Growth in Two Years in Announcement of Third Quarter 2015 Financial Results
November 3, 2015 4:05 PM ESTREDWOOD CITY, Calif., Nov. 3, 2015 /PRNewswire/ --Â Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2015.
Revenue was $73.6 million in the third quarter of 2015 compared with $69.1 million for the third quarter of 2014, an increase of 6 percent. On a constant currency basis, revenue increased 8 percent compared with the same period in the prior year.
U.S. revenue was $63.1 million in the third quarter of 2015, an increase of 9 percent compared with the same period in the prior year. International revenue was $10.5 million in the third... More
